Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Not Allowed)
ID: 344457Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/344457

Additional Information

http://grants.nih.gov/grants/guide/rfa-files/RFA-OD-22-025.html
Timeline
  1. 1
    Forecast Posted Not available
  2. 2
    Forecast Due Not available
  3. 3
    Posted Nov 10, 2022, 12:00 AM UTC
  4. 4
    Due Mar 12, 2025, 12:00 AM UTC
Description

The National Institutes of Health (NIH) is offering the Pathway to Independence Award in Tobacco Regulatory Research (K99/R00) to support the development of new independent researchers focused on tobacco product regulation. This funding opportunity aims to facilitate the transition of outstanding postdoctoral researchers into independent faculty positions, emphasizing research that informs the FDA's regulatory priorities under the Family Smoking Prevention and Tobacco Control Act. The award consists of two phases: a mentored K99 phase lasting up to two years, followed by an independent R00 phase for an additional three years, with a total funding amount of $750,000 available for approximately five awards. Interested applicants must submit their proposals through Grants.gov by the close date of March 12, 2025, and can direct inquiries to grantsinfo@nih.gov for further information.

Point(s) of Contact
grantsinfo@nih.gov
Files
Title
Posted
RFA-OD-22-025.html
Aug 24, 2024, 2:22 AM UTC
The Department of Health and Human Services, through the National Institutes of Health (NIH) and the U.S. Food and Drug Administration (FDA), announces the Pathway to Independence Award in Tobacco Regulatory Research (K99/R00). This funding opportunity aims to cultivate a new cohort of independent researchers focused on tobacco product regulation, emphasizing research that informs FDA regulations in compliance with the Family Smoking Prevention and Tobacco Control Act. The award consists of two phases: the mentored K99 phase, lasting up to two years, followed by the independent R00 phase for an additional three years. Candidates must have no more than four years of postdoctoral experience and should propose research that is relevant to FDA’s regulatory priorities, including tobacco product composition, toxicity, public health impacts, marketing influences, and addiction. Eligible applicants include higher education institutions and qualified individuals with relevant research doctorates. The expected total funding from the FDA is $750,000 for approximately five awards. Applicants must follow strict instructions for submission via Grants.gov, and the application must showcase a well-structured plan for career development and research. The application cycle includes specific due dates, with the first due date occurring on February 21, 2023, emphasizing the need for applicants to plan accordingly.
Similar Opportunities
NCI Pathway to Independence Award (K99/R00 Clinical Trial Required)
National Institutes of Health
The National Institutes of Health (NIH) is offering the NCI Pathway to Independence Award (K99/R00), a federal grant aimed at supporting postdoctoral researchers in their transition to independent faculty positions, specifically in the field of cancer research. This program provides a structured funding mechanism over five years, consisting of a two-year mentored training phase (K99) followed by a three-year independent research phase (R00), with a focus on proposals that align with the NCI's mission. Eligible applicants include a diverse range of institutions, such as historically black colleges and universities, Hispanic-serving institutions, and other nonprofit entities, although candidates must not hold independent research faculty positions and should have no more than six years of postdoctoral experience. Interested applicants can find more information and submit their proposals starting January 27, 2025, with the application deadline set for October 14, 2027. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed)
National Institutes of Health
The National Institutes of Health (NIH) is offering the Pathway to Independence Award (K99/R00), a federal grant aimed at supporting postdoctoral researchers in their transition to independent faculty positions. This program is designed to provide up to five years of funding, divided into two phases: the K99 phase for mentored training and the R00 phase for independent research, specifically targeting individuals with no more than four years of postdoctoral experience. The initiative emphasizes the importance of cultivating a diverse and skilled workforce in biomedical and clinical research, encouraging applications from underrepresented groups. Interested applicants must submit their proposals by May 7, 2027, and can find additional information and application guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
NCI Pathway to Independence Award (K99/R00 Clinical Trial Not Allowed)
National Institutes of Health
The National Institutes of Health (NIH) is offering the NCI Pathway to Independence Award (K99/R00), a federal grant designed to support postdoctoral researchers transitioning to independent faculty positions in cancer research. This program provides funding for up to five years, consisting of a two-year mentored phase (K99) followed by up to three years of independent research support (R00), contingent upon securing a tenure-track position. The initiative aims to foster a diverse and skilled workforce in biomedical research, addressing critical health needs while promoting the career development of emerging investigators. Interested applicants must hold a clinical or research doctorate and have no more than six years of postdoctoral experience at the time of application. The application period opens on January 13, 2025, with a submission deadline of October 14, 2027. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the program's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-25-135.html.
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required)
National Institutes of Health
The National Institutes of Health (NIH) is offering the NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00), aimed at facilitating the transition of postdoctoral fellows to independent faculty positions. This program is specifically designed for researchers with clinical or research doctoral degrees who require minimal additional mentored training and are proposing to lead independent clinical trials or studies. The award consists of two phases: the K99 phase provides up to $100,000 annually for two years of mentored research, followed by the R00 phase, which offers up to $249,000 per year for three years of independent research. Interested applicants must adhere to detailed submission guidelines and can find more information at the provided NIH link. The application deadline is October 14, 2026, and inquiries can be directed to grantsinfo@nih.gov.
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Basic Experimental Studies with Humans Required)
National Institutes of Health
The National Institutes of Health (NIH), through the National Cancer Institute (NCI), is offering the K99/R00 Pathway to Independence Award aimed at supporting early-stage postdoctoral researchers transitioning to independent research positions. This funding opportunity is designed for postdoctoral fellows with research or clinical doctoral degrees, focusing on studies involving human participants that meet the NIH definitions of clinical trials and basic research, particularly in cancer control, prevention, and data sciences. The program consists of a two-phase structure: the K99 phase provides up to two years of mentored support, while the R00 phase offers up to three years of independent research funding, contingent on progress and securing a faculty position. Interested applicants must adhere to strict guidelines and institutional nominations, with key deadlines approaching in January 2024. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-23-288.html.
High-Priority Research in Tobacco Regulatory Science (R01 Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health (NIH) is offering a funding opportunity for "High-Priority Research in Tobacco Regulatory Science" aimed at advancing scientific understanding of tobacco products to inform regulations by the Food and Drug Administration (FDA). This initiative invites R01 applications focused on critical research areas, including addiction, health impacts, and the toxicity of electronic nicotine delivery systems (ENDS) and other tobacco products. The funding is crucial for generating data that will guide FDA's regulatory decisions, ultimately protecting public health. Each application can request up to $500,000 per year for a project period of up to five years, with a total of $4 million available across five awards. Applications are due by June 7, 2025, and interested parties can contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed)
National Institutes of Health
The National Institutes of Health (NIH) is offering the NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00), aimed at facilitating the transition of postdoctoral fellows into independent faculty positions in cancer research. This grant program is designed for researchers with doctoral degrees who require minimal additional mentored training, providing up to two years of support during the K99 phase followed by up to three years of independent research funding in the R00 phase. The initiative underscores NIH's commitment to strengthening the workforce in cancer research, particularly in areas such as cancer control and prevention, while ensuring that applicants present a comprehensive career development plan and mentorship strategy. Applications will open on January 14, 2024, with potential awards beginning in February 2024; interested parties can contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
NIH Pathway to Independence Award (Parent K99/R00 Independent Basic Experimental Studies with Humans Required)
National Institutes of Health
The National Institutes of Health (NIH) is offering the Pathway to Independence Award (K99/R00), a federal grant aimed at supporting exceptional postdoctoral researchers in their transition to independent faculty positions while conducting basic experimental studies involving human subjects. This program is designed to facilitate a timely shift from mentored postdoctoral roles to independent research careers, providing funding for up to five years, divided into a mentored K99 phase (up to two years) and an independent R00 phase (up to three years), contingent upon successful transition to tenure-track or equivalent positions. Eligible applicants include a diverse range of institutions, such as Historically Black Colleges and Universities and Tribal Colleges, with key application deadlines starting May 10, 2024, and the final submission date set for May 7, 2027. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the program's webpage for additional details.
Tobacco Regulatory Science (R01 Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health (NIH) is inviting applications for the "Tobacco Regulatory Science (R01 Clinical Trial Optional)" funding opportunity, aimed at supporting biomedical and behavioral research to inform the regulation of tobacco products and protect public health. This initiative seeks R01 research project grant applications that address key research priorities, including the composition and design of tobacco products, toxicity assessments, addiction studies, and the health effects of tobacco use. A total of up to six R01 grants, with a combined funding of $4 million for fiscal year 2024, will be awarded to eligible applicants, which include a diverse range of institutions and organizations. Interested parties should submit their applications by May 4, 2025, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-23-017.html for further details.
NIAID Physician-Scientist Pathway to Independence Award (K99/R00 Clinical Trial Required)
National Institutes of Health
The National Institutes of Health (NIH) is offering the NIAID Physician-Scientist Pathway to Independence Award (K99/R00), a federal grant aimed at enhancing the number of independent physician-scientists in biomedical research. This program is specifically designed for outstanding postdoctoral researchers with clinical doctorate degrees who are transitioning from mentored positions to independent faculty roles, providing up to four years of funding divided into two phases: up to two years of mentored training followed by up to two years of independent research support. The initiative addresses the national shortage of physician-scientists and emphasizes the importance of a strong mentoring environment to facilitate successful transitions to research independence. Interested applicants must submit their proposals by January 7, 2026, and can find additional information and application details at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.